GC Corp. (KRX:005250)

Market Cap	710.99B +18.2%
Revenue (ttm)	2.45T +11.2%
Net Income	-68.80B
EPS	-1,531.09
Shares Out	45.40M
PE Ratio	n/a
Forward PE	n/a
Dividend	300.00 (1.95%)
Ex-Dividend Date	Mar 30, 2026

Volume	3,153,980
Average Volume	495,685
Open	15,030
Previous Close	15,660
Day's Range	15,030 - 17,550
52-Week Range	12,940 - 18,010
Beta	0.59
RSI	59.17
Earnings Date	Apr 3, 2026

About GC Corp.

Green Cross Holdings Corporation operates as a biotechnology company. The company provides plasma derivatives, prescription drugs, over the counter drugs, and hunter syndrome drugs; and vaccines for hemorrhagic fever, varicella, hepatitis-B, and flu. It also researches and develops oncology, immunology, and cell therapy products; and offers recombinant protein treatment for hemophilia. The company has partnerships and collaborations with biotech companies and academia for development of new drugs and technologies. Green Cross Holdings was found...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 1967
• Country: South Korea
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 005250